More on BHVN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.7 Score)
- Holders
- Event Driven Deals

Upcoming Events

- Earnings (8/4/26 *Est.)
- M&A (3/31/23 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Biohaven Pharma (NY:BHVN)
Delayed: 9.92 -0.39 (3.78%)
Prev. Close $10.31  
Open$10.05 
52 Wk High$ 
52 Wk Low$ 
Day High$10.22 
Day Low$9.70 
P/E N/A  
EPS$ 
Volume2,220,962 

Friends, Peers and Foes (?): QURE, REGN, ALNY, BEAM, BMRN (more...)

Mar 4, 2026 06:41 AM Biohaven Pharma (BHVN) PT Lowered to $10 at H.C. Wainwright
Mar 3, 2026 06:09 PM Form 4 Biohaven Ltd. For: Feb 27 Filed by: Buten Matthew
Mar 3, 2026 06:08 PM Form 4 Biohaven Ltd. For: Feb 27 Filed by: Gentile Kimberly
Mar 3, 2026 06:08 PM Form 4 Biohaven Ltd. For: Feb 27 Filed by: Clark George C.
Mar 3, 2026 06:08 PM Form 4 Biohaven Ltd. For: Feb 27 Filed by: Car Bruce
Mar 3, 2026 06:04 PM Form 4 Biohaven Ltd. For: Feb 27 Filed by: Coric Vlad
Mar 3, 2026 02:43 PM Leerink Partners Reiterates Outperform Rating on Biohaven Pharma (BHVN), lowers EPS estimates
Mar 3, 2026 09:01 AM Biohaven Pharma (BHVN) PT Raised to $23 at RBC Capital
Mar 3, 2026 08:43 AM Piper Sandler: 'Biohaven Pharma (BHVN) Gearing Up for a Catalyst-Rich 2026'
Mar 2, 2026 08:18 PM Biohaven Pharma (BHVN) Tops Q4 EPS by 28c
View All Articles

Entities mentioned with BHVN

View All Entities